Cannabidiol Market Size, Trends, Analysis, and Outlook By Source (Hemp, Marijuana), By B2B Sales (Pharmaceuticals, Wellness), By B2C Sales Channel (Hospital Pharmacies, Online, Retail Stores), By B2C End User (Medical, Personal Use), By End-User (Medical,

Cannabidiol Market Size, Trends, Analysis, and Outlook By Source (Hemp, Marijuana), By B2B Sales (Pharmaceuticals, Wellness), By B2C Sales Channel (Hospital Pharmacies, Online, Retail Stores), By B2C End User (Medical, Personal Use), By End-User (Medical, Personal Use, Pharmaceuticals, Wellness), by Region, Country, Segment, and Companies, 2024-2030

The global Cannabidiol market size is poised to register 16.01% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cannabidiol market across By Source (Hemp, Marijuana), By B2B Sales (Pharmaceuticals, Wellness), By B2C Sales Channel (Hospital Pharmacies, Online, Retail Stores), By B2C End User (Medical, Personal Use), By End-User (Medical, Personal Use, Pharmaceuticals, Wellness).

The Cannabidiol Market is witnessing significant growth and therapeutic innovation in 2024 and beyond, driven by advancements in cannabis research, cannabinoid pharmacology, and medical cannabis legalization initiatives aimed at exploring the therapeutic potential of cannabidiol (CBD), a non-intoxicating cannabinoid compound derived from hemp or marijuana plants, for managing various medical conditions, including chronic pain, anxiety, epilepsy, insomnia, and inflammatory disorders, as well as for promoting health and wellness in consumers seeking natural remedies, alternative therapies, and plant-based supplements for improving their physical, mental, and emotional well-being in diverse demographic populations worldwide. Cannabidiol (CBD) is a phytocannabinoid with analgesic, anxiolytic, anticonvulsant, and anti-inflammatory properties that interacts with the endocannabinoid system (ECS), a complex network of cannabinoid receptors, endogenous cannabinoids, and metabolic enzymes involved in regulating mood, cognition, pain perception, and immune function, offering potential therapeutic benefits, symptom relief, and disease-modifying effects for patients with chronic medical conditions, neurological disorders, and mental health disorders that are refractory to conventional treatments or associated with treatment-related side effects, dependency risks, or adverse reactions in clinical practice. Key trends include the development of CBD-infused products, hemp-derived CBD extracts, and pharmaceutical-grade CBD formulations that meet quality standards, purity requirements, and regulatory guidelines for safety, potency, and consistency, as well as the integration of CBD into healthcare products, wellness supplements, and lifestyle brands targeting specific health conditions, functional benefits, or consumer preferences, such as CBD oils, tinctures, capsules, topicals, and edibles, that offer alternative treatment options, holistic health solutions, and personalized wellness experiences for individuals seeking natural alternatives to conventional medications, over-the-counter drugs, or prescription therapies. Additionally, there is a growing emphasis on CBD research, clinical trials, and evidence-based medicine that evaluate CBD efficacy, safety, and pharmacokinetics in diverse patient populations, as well as a growing focus on regulatory oversight, quality assurance, and product labeling standards that ensure transparency, consumer protection, and regulatory compliance in the CBD industry, fostering consumer confidence, market credibility, and sustainable growth in the global CBD market.

Cannabidiol Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cannabidiol market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cannabidiol survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cannabidiol industry.

Key market trends defining the global Cannabidiol demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Cannabidiol Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Cannabidiol industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cannabidiol companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Cannabidiol industry

Leading Cannabidiol companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cannabidiol companies.

Cannabidiol Market Study- Strategic Analysis Review

The Cannabidiol market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Cannabidiol Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Cannabidiol industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Cannabidiol Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Cannabidiol Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cannabidiol market segments. Similarly, Strong end-user demand is encouraging Canadian Cannabidiol companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cannabidiol market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Cannabidiol Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Cannabidiol industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cannabidiol market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Cannabidiol Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cannabidiol in Asia Pacific. In particular, China, India, and South East Asian Cannabidiol markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Cannabidiol Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Cannabidiol Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cannabidiol market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cannabidiol.

Cannabidiol Market Company Profiles

The global Cannabidiol market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ENDOCA, Cannoid LLC, Canopy Growth Corp, Elixinol, Folium Europe B.V., Isodiol International Inc, Medical Marijuana Inc, NuLeaf Naturals LLC, PharmaHemp, The Cronos Group

Recent Cannabidiol Market Developments

The global Cannabidiol market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Cannabidiol Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Source

Hemp

Marijuana

By B2B Sales Type

Pharmaceuticals

Wellness

-Food & Beverages

-Personal Care & Cosmetics

-Nutraceuticals

-Others

By B2C Sales Channel

Hospital Pharmacies

Online

Retail Stores

By B2C End-user

Medical

-Chronic Pain

-Mental Disorders

-Cancer

-Others

Personal Use

By End-user

Medical

-Chronic Pain

-Mental Disorders

-Cancer

-Others

Personal Use

Pharmaceuticals

Wellness

-Food & Beverages

-Personal Care & Cosmetics

-Nutraceuticals

-Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

ENDOCA

Cannoid LLC

Canopy Growth Corp

Elixinol

Folium Europe B.V.

Isodiol International Inc

Medical Marijuana Inc

NuLeaf Naturals LLC

PharmaHemp

The Cronos Group

Formats Available: Excel, PDF, and PPT